IIT Guwahati collaborates with NECHRI Jorabat to identify novel biomarkers for cancer

The MoU will enable IIT Guwahati and NECHRI to strengthen more collaborations and to help cancer patients from NE region.

The Indian Institute of Technology (IIT) Guwahati has announced that it has signed a Memorandum of Understanding (MoU) with the North East Cancer Hospital and Research Institute (NECHRI), Jorabat. The MoU signing ceremony was organised at the institute. Both IIT Guwahati and NECHRI have been engaged in identifying novel biomarkers for cancer diagnosis, prognosis, therapy and recurrence.

They have also been engaged in identifying cancer susceptible population from Northeast India. This collaboration has already identified novel targets for oral cancer (a leading cancer burden in India) drug discovery. The research has been published in the highly reputed International Journal ‘Biomolecules’ in 2019.

“Based on these results, both IIT Guwahati and NECHRI have been conducting research to develop novel drugs for the treatment of oral cancer. In addition, both the institutions are engaged in developing various strategies to help cancer patients from the Northeast region,” IIT Guwahati in a statement.

The MoU will enable IIT Guwahati and NECHRI to strengthen more collaborations and to help cancer patients from NE region. In addition, studies have been already started to identify different cancer susceptible populations from the Northeast region and to help to prevent this deadly disease among these populations.

Recently, a joint project proposal has been submitted by NECHRI and IIT Guwahati to ICMR to identify novel therapeutic targets for Triple Negative Breast Cancer from Northeast patients. In addition, both institutions have shared their expertise as resource persons in different conferences and workshops organized.

Commenting on the MoU, Prof. T. G. Sitharam, director, IIT Guwahati said, “IIT Guwahati has world-class expertise and infrastructure in cancer research and is committed to helping the Northeast region.” The aim of this MoU is to initiate more active collaboration with NECHRI and to identify different biomarkers for the early diagnosis of cancer and cancer drug discovery. This MoU would help both the institutions to conduct interdisciplinary research in cancer and share the expertise between clinicians and scientists.

Read More:

• IIT Guwahati Courses & Fees 2021
• IIT Guwahati Admission 2020 for BTech, MTech and Phd